Discovery of cyclic peptide natural product inhibitors of
Chenyang Lu,Samantha Nelson,Gabriela Coy,Christopher Neumann,Elizabeth I. Parkinson,Christopher A. Rice
DOI: https://doi.org/10.1101/2024.05.03.592372
2024-05-05
Abstract:is a pathogenic free-living amoeba that causes infection of central nervous system, called amoebic encephalitis (BAE), as well as cutaneous and systemic diseases. Patients infected with have a high mortality rate due to the lack of effective treatments. A combination of non-optimized antimicrobial drug regimen is typically recommended; however, they have poor parasite activity and can cause various severe side effects. Cyclic peptides exhibit a broad spectrum of antimicrobial activities and lower cytotoxicity. In this study, we evaluated the anti- effect of cyclic peptides. The predicted natural product-43 (pNP-43), identified from the SNaPP (Synthetic Natural Product Inspired Cyclic Peptides) library, and its derivates displayed a significant inhibition for trophozoites. Eight pNPs had IC s <5 μM. Furthermore, all hit pNPs demonstrated minimal hemolytic and cytotoxic effects on human cells. Our study first indicates the anti- effect of cyclic peptides, which provides a new direction for drug development. Further studies of the mechanism of action and effects will be elucidated to confirm the potency as a treatment for infection in the future.
Pharmacology and Toxicology
What problem does this paper attempt to address?
This paper focuses on the discovery of cyclic peptide natural product inhibitors to combat Balamuthia mandrillaris, a pathogenic free-living amoeba that causes central nervous system infections (Balamuthia encephalitis) and other diseases. Currently, the treatment for this pathogen is ineffective, with a high mortality rate. The research team screened a synthetic natural product-inspired cyclic peptide library (SNaPP) they developed and found a cyclic peptide called pNP-43 and its derivatives that showed significant inhibitory effects against B. mandrillaris, with low toxicity and cytotoxicity. These findings provide a new direction for the development of novel therapeutic drugs, and further research will be conducted to investigate their mechanisms of action and in vivo effectiveness to confirm their therapeutic potential.